Literature DB >> 5790245

Histopathology of gestational rubella.

S G Driscoll.   

Abstract

Entities:  

Mesh：

Year:  1969        PMID： 5790245     DOI： 10.1001/archpedi.1969.02100040051009

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN： 0002-922X


× No keyword cloud information.
  8 in total

1.  Intrauterine infections.

Authors:  P N Sheth; U V Kolhatkar; G G Bhave; N Wagale
Journal:  Indian J Pediatr       Date:  1985 Nov-Dec       Impact factor: 1.967

2.  Teratogenic effect of rubella virus.

Authors:  J A Dudgeon
Journal:  Proc R Soc Med       Date:  1970-12

3.  Placental and fetal alterations due to Venezuelan equine encephalitis virus in rats.

Authors:  J García-Tamayo; J Esparza; A J Martínez
Journal:  Infect Immun       Date:  1981-05       Impact factor: 3.441

4.  Multicystic encephalomalacia due to fetal viral encephalitis.

Authors:  K R Lyen; S Lingam; A M Butterfill; W C Marshall; C J Dobbing; D S Lee
Journal:  Eur J Pediatr       Date:  1981-09       Impact factor: 3.183

5.  Immunolocalization and Distribution of Rubella Antigen in Fatal Congenital Rubella Syndrome.

Authors:  Mihaela Lazar; Ludmila Perelygina; Roosecelis Martines; Patricia Greer; Christopher D Paddock; Gheorghe Peltecu; Emilia Lupulescu; Joseph Icenogle; Sherif R Zaki
Journal:  EBioMedicine       Date:  2015-11-27       Impact factor: 8.143

6.  Analysis of VSV pseudotype virus infection mediated by rubella virus envelope proteins.

Authors:  Masafumi Sakata; Hideki Tani; Masaki Anraku; Michiyo Kataoka; Noriyo Nagata; Fumio Seki; Maino Tahara; Noriyuki Otsuki; Kiyoko Okamoto; Makoto Takeda; Yoshio Mori
Journal:  Sci Rep       Date:  2017-09-14       Impact factor: 4.379

7.  Persistent infection of human fetal endothelial cells with rubella virus.

Authors:  Ludmila Perelygina; Qi Zheng; Maureen Metcalfe; Joseph Icenogle
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

8.  Inhibition of rubella virus replication by the broad-spectrum drug nitazoxanide in cell culture and in a patient with a primary immune deficiency.

Authors:  Ludmila Perelygina; Timo Hautala; Mikko Seppänen; Adebola Adebayo; Kathleen E Sullivan; Joseph Icenogle
Journal:  Antiviral Res       Date:  2017-09-30       Impact factor: 5.970
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.